Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
-
Publication Venue For
-
AGA Institute Quality Indicator Development and Uses..
21:1399-1402.
2023
-
Impact of Artificial Intelligence on Colonoscopy Surveillance After Polyp Removal: A Pooled Analysis of Randomized Trials..
21:949-959.e2.
2023
-
Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B.
2023
-
Quality Improvement Training for Gastroenterology and Hepatology Fellowship: More Than Just a GME Requirement.
2023
-
Confronting Disparities in Telehepatology Research.
2022
-
An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States..
20:2218-2228.e2.
2022
-
How to Train the Next Generation to Provide High-Quality Peer-Reviews..
20:1902-1906.
2022
-
Safety and sustained efficacy of the farnesoid X receptor (FXR) agonist cilofexor over a 96-week open-label extension in patients with PSC.
2022
-
Deep Learning Computer-aided Polyp Detection Reduces Adenoma Miss Rate: A United States Multi-center Randomized Tandem Colonoscopy Study (CADeT-CS Trial)..
20:1499-1507.e4.
2022
-
Reply..
20:1614.
2022
-
Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury..
20:e1416-e1425.
2022
-
Practice Management: The Road Taken and the Road Ahead..
20:1205-1208.
2022
-
Therapeutics, Placebo, and the Importance of Hard Outcomes in Irritable Bowel Syndrome Research..
20:e921-e922.
2022
-
Reply..
20:714-715.
2022
-
Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus..
20:256-268.
2022
-
Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response..
20:438-446.
2022
-
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States..
20:183-193.
2022
-
Centers of Excellence in Hepatology: Making the Case to Insurers, Large Employers, and Patients..
19:2464-2468.
2021
-
Issue Highlights..
19:2223-2225.
2021
-
Health Equity and Telemedicine in Gastroenterology and Hepatology..
19:1516-1519.
2021
-
An Impetus for Change: How COVID-19 Will Transform the Delivery of GI Health Care..
19:1310-1313.
2021
-
Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease..
19:1480-1488.e14.
2021
-
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study..
19:1469-1479.e19.
2021
-
Scoping Out a Better Parental Leave Policy for Gastroenterology Fellows..
19:1307-1309.
2021
-
Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis..
19:1248-1257.
2021
-
Testosterone is Associated With Nonalcoholic Steatohepatitis and Fibrosis in Premenopausal Women With NAFLD..
19:1267-1274.e1.
2021
-
Comparison of Assays for Therapeutic Monitoring of Infliximab and Adalimumab in Patients With Inflammatory Bowel Diseases..
19:839-841.e2.
2021
-
Patient Safety Reporting in GI: All Hands on Deck..
19:629-632.e1.
2021
-
Unconscious Bias in Peer Review..
19:419-420.
2021
-
Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men..
19:400-402.e2.
2021
-
C.O.V.I.D.: A Survival Guide for GI Fellowship Training During the COVID-19 Pandemic..
19:6-9.
2021
-
Education and Trainee Perspectives Section..
19:5.
2021
-
Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection..
18:2544-2553.e6.
2020
-
What Clues Can We Use From Primary Sclerosing Cholangitis With Inflammatory Bowel Disease Phenotypes?.
18:2173-2175.
2020
-
Higher Esophageal Symptom Burden in Obese Subjects Results From Increased Esophageal Acid Exposure and Not From Dysmotility..
18:1719-1726.
2020
-
Great Expectations: Can Magnetic Resonance Elastography Accelerate Progress in Primary Sclerosing Cholangitis Research?.
18:1436-1438.
2020
-
Increasing Testing for Helicobacter pylori Infection to Improve Quality of Patient Care..
18:1028-1029.
2020
-
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma..
18:974-983.
2020
-
Mean Nocturnal Baseline Impedance Correlates With Symptom Outcome When Acid Exposure Time Is Inconclusive on Esophageal Reflux Monitoring..
18:589-595.
2020
-
Development of Quality Measures for Acute Pancreatitis: A Model for Hospital-Based Measures in Gastroenterology..
18:272-275.e5.
2020
-
Long-term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients With Chronic Hepatitis C Virus Infection..
18:468-476.e11.
2020
-
Variation Among Patients With Crohn's Disease in Benefit vs Risk Preferences and Remission Time Equivalents..
18:406-414.e7.
2020
-
Is Magnetic Resonance Cholangiopancreatography Worth a Thousand Words in Determining Prognoses of Patients With Primary Sclerosing Cholangitis?.
17:2654-2656.
2019
-
Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection..
17:2541-2551.e2.
2019
-
Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage..
17:1877-1885.e5.
2019
-
Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis..
17:1867-1876.e3.
2019
-
Decreasing Endoscopy No-Shows Using a Lean Improvement Framework..
17:1224-1227.e3.
2019
-
Sclerosing Cholangitis-Like Changes on Magnetic Resonance Cholangiography in Patients With Drug Induced Liver Injury..
17:789-790.
2019
-
Issue Highlights..
16:1539-1540.
2018
-
Reply..
16:1684.
2018
-
Diagnosing Liver Fibrosis and Cirrhosis: Serum, Imaging, or Tissue?.
16:16-18.
2018
-
Hepatocellular Carcinoma Surveillance..
16:19-20.
2018
-
Issue Highlights..
15:1483-1484.
2017
-
Bolus Administration of Fentanyl and Midazolam for Colonoscopy Increases Endoscopy Unit Efficiency and Safety Compared With Titrated Sedation..
15:1419-1426.e2.
2017
-
The Evolving Payment Reform Landscape: New Opportunities for Gastroenterology Leadership..
15:1322-1325.
2017
-
Cultivating Competencies for Value-Based Care..
15:969-971.
2017
-
Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy..
15:1087-1094.e2.
2017
-
White Paper AGA: An Episode-of-Care Framework for the Management of Obesity-Moving Toward High Value, High Quality Care: A Report From the American Gastroenterological Association Institute Obesity Episode of Care and Bundle Initiative Work Group..
15:650-664.e2.
2017
-
Efficacy of Sofosbuvir Plus Ribavirin in Veterans With Hepatitis C Virus Genotype 2 Infection, Compensated Cirrhosis, and Multiple Comorbidities..
15:282-288.
2017
-
Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury..
15:103-112.e2.
2017
-
Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis..
15:127-131.e2.
2017
-
Loss of Peristaltic Reserve, Determined by Multiple Rapid Swallows, Is the Most Frequent Esophageal Motility Abnormality in Patients With Systemic Sclerosis..
14:1502-1506.
2016
-
Colorectal Cancer Screening Quality Measures: Beyond Colonoscopy..
14:644-647.
2016
-
A Novel Electronic Medical Record-Based Workflow to Measure and Report Colonoscopy Quality Measures..
14:333-337.e1.
2016
-
Reply..
14:486.
2016
-
Factors Associated With Missed and Cancelled Colonoscopy Appointments at Veterans Health Administration Facilities..
14:259-267.
2016
-
Hepatitis C Virus Treatment: Is It Possible To Cure All Hepatitis C Virus Patients?.
13:2166-2172.
2015
-
Bridging the G-APP: Continuous Professional Development for Gastroenterologists: Replacing MOC with a Model for Lifelong Learning and Accountability.
2015
-
Variation in Aptitude of Trainees in Endoscopic Ultrasonography, Based on Cumulative Sum Analysis..
13:1318-1325.e2.
2015
-
Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease..
13:884-891.
2015
-
Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study..
13:772-9.e1-3.
2015
-
Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype..
13:183-192.
2015
-
Multiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C..
12:2113-20.e1-3.
2014
-
Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome..
12:1550-1555.
2014
-
Iron deficiency in patients with nonalcoholic Fatty liver disease is associated with obesity, female gender, and low serum hepcidin..
12:1170-1178.
2014
-
Reply: To PMID 23978500..
12:527.
2014
-
Endoscopy unit efficiency: quality redefined..
11:1046-1049.e1.
2013
-
Obese humans with nonalcoholic fatty liver disease display alterations in fecal microbiota and volatile organic compounds..
11:876-878.
2013
-
Covert hepatic encephalopathy: not as minimal as you might think..
10:1208-1219.
2012
-
Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease..
10:1028-33.e2.
2012
-
Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection..
10:932-937.e1.
2012
-
Association between puberty and features of nonalcoholic fatty liver disease..
10:786-794.
2012
-
Patients with autoimmune hepatitis who have antimitochondrial antibodies need long-term follow-up to detect late development of primary biliary cirrhosis..
10:682-684.
2012
-
Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease..
9:868-874.
2011
-
Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3..
9:688-693.
2011
-
Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic Fatty liver disease..
8:1062-1069.
2010
-
Gastric ulceration in a patient treated with SIR-spheres..
8:A22.
2010
-
Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease..
8:268-274.
2010
-
Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease..
7:1104-1112.
2009
-
A retroperitoneal bronchogenic cyst..
7:A24-Ae1.
2009
-
Co-medications that modulate liver injury and repair influence clinical outcome of acetaminophen-associated liver injury..
7:882-888.
2009
-
A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome..
7:706-708.e1.
2009
-
Imaging approach for evaluation of focal liver lesions..
7:624-634.
2009
-
Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C..
7:212-218.
2009
-
Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patients..
6:701-706.
2008
-
Image of the month. Syphilitic proctitis..
6:xxvi.
2008
-
Image of the month. Syphilitic proctitis..
6.
2008
-
Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy..
6:290-297.
2008
-
Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C..
6:242-247.
2008
-
Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis..
5:259-264.
2007
-
Reply..
14:1845-1846.
2016